Copyright Reports & Markets. All rights reserved.

Global Viral Testing Market Research Report 2021

Request for Sample of this report
Buy now

1 Viral Testing Market Overview

  • 1.1 Product Overview and Scope of Viral Testing
  • 1.2 Viral Testing Segment by Type
    • 1.2.1 Global Viral Testing Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Direct Fluorescent Antibody (DFA) Test
    • 1.2.3 Immunochromatographic Assay
    • 1.2.4 RT-PCR-Based Test
    • 1.2.5 Agglutination Assay
    • 1.2.6 Flow-Through Assay
    • 1.2.7 Solid-Phase Assay
  • 1.3 Viral Testing Segment by Application
    • 1.3.1 Viral Testing Sales Comparison by Application: (2021-2027)
    • 1.3.2 Laboratory
    • 1.3.3 Hospital
    • 1.3.4 Home Care
    • 1.3.5 Academic Institute
  • 1.4 Global Viral Testing Market Size Estimates and Forecasts
    • 1.4.1 Global Viral Testing Revenue 2016-2027
    • 1.4.2 Global Viral Testing Sales 2016-2027
    • 1.4.3 Viral Testing Market Size by Region: 2016 Versus 2021 Versus 2027

2 Viral Testing Market Competition by Manufacturers

  • 2.1 Global Viral Testing Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Viral Testing Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Viral Testing Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Viral Testing Manufacturing Sites, Area Served, Product Type
  • 2.5 Viral Testing Market Competitive Situation and Trends
    • 2.5.1 Viral Testing Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Viral Testing Players Market Share by Revenue
    • 2.5.3 Global Viral Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Viral Testing Retrospective Market Scenario by Region

  • 3.1 Global Viral Testing Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Viral Testing Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Viral Testing Market Facts & Figures by Country
    • 3.3.1 North America Viral Testing Sales by Country
    • 3.3.2 North America Viral Testing Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Viral Testing Market Facts & Figures by Country
    • 3.4.1 Europe Viral Testing Sales by Country
    • 3.4.2 Europe Viral Testing Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Viral Testing Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Viral Testing Sales by Region
    • 3.5.2 Asia Pacific Viral Testing Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Viral Testing Market Facts & Figures by Country
    • 3.6.1 Latin America Viral Testing Sales by Country
    • 3.6.2 Latin America Viral Testing Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Viral Testing Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Viral Testing Sales by Country
    • 3.7.2 Middle East and Africa Viral Testing Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Viral Testing Historic Market Analysis by Type

  • 4.1 Global Viral Testing Sales Market Share by Type (2016-2021)
  • 4.2 Global Viral Testing Revenue Market Share by Type (2016-2021)
  • 4.3 Global Viral Testing Price by Type (2016-2021)

5 Global Viral Testing Historic Market Analysis by Application

  • 5.1 Global Viral Testing Sales Market Share by Application (2016-2021)
  • 5.2 Global Viral Testing Revenue Market Share by Application (2016-2021)
  • 5.3 Global Viral Testing Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Roche
    • 6.1.1 Roche Corporation Information
    • 6.1.2 Roche Description and Business Overview
    • 6.1.3 Roche Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Roche Product Portfolio
    • 6.1.5 Roche Recent Developments/Updates
  • 6.2 Agilent Technologies
    • 6.2.1 Agilent Technologies Corporation Information
    • 6.2.2 Agilent Technologies Description and Business Overview
    • 6.2.3 Agilent Technologies Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Agilent Technologies Product Portfolio
    • 6.2.5 Agilent Technologies Recent Developments/Updates
  • 6.3 Thermo Fisher Scientific
    • 6.3.1 Thermo Fisher Scientific Corporation Information
    • 6.3.2 Thermo Fisher Scientific Description and Business Overview
    • 6.3.3 Thermo Fisher Scientific Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Thermo Fisher Scientific Product Portfolio
    • 6.3.5 Thermo Fisher Scientific Recent Developments/Updates
  • 6.4 QIAGEN International
    • 6.4.1 QIAGEN International Corporation Information
    • 6.4.2 QIAGEN International Description and Business Overview
    • 6.4.3 QIAGEN International Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 QIAGEN International Product Portfolio
    • 6.4.5 QIAGEN International Recent Developments/Updates
  • 6.5 Lonza
    • 6.5.1 Lonza Corporation Information
    • 6.5.2 Lonza Description and Business Overview
    • 6.5.3 Lonza Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Lonza Product Portfolio
    • 6.5.5 Lonza Recent Developments/Updates
  • 6.6 Wuxi Pharmatech (Cayman)
    • 6.6.1 Wuxi Pharmatech (Cayman) Corporation Information
    • 6.6.2 Wuxi Pharmatech (Cayman) Description and Business Overview
    • 6.6.3 Wuxi Pharmatech (Cayman) Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Wuxi Pharmatech (Cayman) Product Portfolio
    • 6.6.5 Wuxi Pharmatech (Cayman) Recent Developments/Updates
  • 6.7 Merck
    • 6.6.1 Merck Corporation Information
    • 6.6.2 Merck Description and Business Overview
    • 6.6.3 Merck Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Merck Product Portfolio
    • 6.7.5 Merck Recent Developments/Updates
  • 6.8 Eurofins Scientific
    • 6.8.1 Eurofins Scientific Corporation Information
    • 6.8.2 Eurofins Scientific Description and Business Overview
    • 6.8.3 Eurofins Scientific Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Eurofins Scientific Product Portfolio
    • 6.8.5 Eurofins Scientific Recent Developments/Updates
  • 6.9 General Electric
    • 6.9.1 General Electric Corporation Information
    • 6.9.2 General Electric Description and Business Overview
    • 6.9.3 General Electric Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 General Electric Product Portfolio
    • 6.9.5 General Electric Recent Developments/Updates
  • 6.10 Danaher
    • 6.10.1 Danaher Corporation Information
    • 6.10.2 Danaher Description and Business Overview
    • 6.10.3 Danaher Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Danaher Product Portfolio
    • 6.10.5 Danaher Recent Developments/Updates
  • 6.11 Bio-Rad Laboratories
    • 6.11.1 Bio-Rad Laboratories Corporation Information
    • 6.11.2 Bio-Rad Laboratories Viral Testing Description and Business Overview
    • 6.11.3 Bio-Rad Laboratories Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Bio-Rad Laboratories Product Portfolio
    • 6.11.5 Bio-Rad Laboratories Recent Developments/Updates
  • 6.12 BD
    • 6.12.1 BD Corporation Information
    • 6.12.2 BD Viral Testing Description and Business Overview
    • 6.12.3 BD Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 BD Product Portfolio
    • 6.12.5 BD Recent Developments/Updates
  • 6.13 Biospherix
    • 6.13.1 Biospherix Corporation Information
    • 6.13.2 Biospherix Viral Testing Description and Business Overview
    • 6.13.3 Biospherix Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Biospherix Product Portfolio
    • 6.13.5 Biospherix Recent Developments/Updates
  • 6.14 Novogene Corporation
    • 6.14.1 Novogene Corporation Corporation Information
    • 6.14.2 Novogene Corporation Viral Testing Description and Business Overview
    • 6.14.3 Novogene Corporation Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Novogene Corporation Product Portfolio
    • 6.14.5 Novogene Corporation Recent Developments/Updates
  • 6.15 Sartorius
    • 6.15.1 Sartorius Corporation Information
    • 6.15.2 Sartorius Viral Testing Description and Business Overview
    • 6.15.3 Sartorius Viral Testing Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Sartorius Product Portfolio
    • 6.15.5 Sartorius Recent Developments/Updates

7 Viral Testing Manufacturing Cost Analysis

  • 7.1 Viral Testing Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Viral Testing
  • 7.4 Viral Testing Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Viral Testing Distributors List
  • 8.3 Viral Testing Customers

9 Viral Testing Market Dynamics

  • 9.1 Viral Testing Industry Trends
  • 9.2 Viral Testing Growth Drivers
  • 9.3 Viral Testing Market Challenges
  • 9.4 Viral Testing Market Restraints

10 Global Market Forecast

  • 10.1 Viral Testing Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Viral Testing by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Viral Testing by Type (2022-2027)
  • 10.2 Viral Testing Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Viral Testing by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Viral Testing by Application (2022-2027)
  • 10.3 Viral Testing Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Viral Testing by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Viral Testing by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Direct Fluorescent Antibody (DFA) Test
    Immunochromatographic Assay
    RT-PCR-Based Test
    Agglutination Assay
    Flow-Through Assay
    Solid-Phase Assay

    Segment by Application
    Laboratory
    Hospital
    Home Care
    Academic Institute

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Roche
    Agilent Technologies
    Thermo Fisher Scientific
    QIAGEN International
    Lonza
    Wuxi Pharmatech (Cayman)
    Merck
    Eurofins Scientific
    General Electric
    Danaher
    Bio-Rad Laboratories
    BD
    Biospherix
    Novogene Corporation
    Sartorius

    Buy now